Skip to main content
SpringerLink
Log in

Addictive Disorders and Pain

  • Chapter
  • First Online:
Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches

  • 4213 Accesses

Abstract

People consume opioids for many reasons, some medically beneficial and others harmful to themselves and to society. It is difficult to conclude that opioid use is harmful by evaluating consumption alone. Consider a population of individuals none of whom have been exposed to opioid use. Within that population are those who do not have addictive disease involving opioids; these individuals will not demonstrate signs and symptoms of addiction whether exposed to opioids or not. A smaller group within the population has addictive disease. Some in this group do not know they have addictive disease simply because they have never been exposed to opioids. Phenotypically, then, they do not have addiction despite the underlying physiology. Another group of individuals, however, will show signs of addiction, resulting from medical or nonmedical use of opioids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8(7):573–82.

    PubMed  CAS  Google Scholar 

  2. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6(6):432–42.

    Article  PubMed  Google Scholar 

  3. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.

    Article  PubMed  Google Scholar 

  4. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370–8.

    Article  PubMed  Google Scholar 

  5. Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT, Oslin DW. The association between chronic pain and prescription drug abuse in veterans. Pain Med. 2009;10(3):531–6.

    Article  PubMed  Google Scholar 

  6. Hennecke L. Stimulus augmenting and field dependence in children of alcoholic fathers. J Stud Alcohol Drugs. 1984;45(6):486–92.

    CAS  Google Scholar 

  7. Public policy statement on the rights and responsibilities of healthcare professionals in the use of opioids for the treatment of pain: a consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Adopted 2004. Available at http://www.ampainsoc.org/advocacy/pdf/rights.pdf. Accessed 7 Jan 2010.

  8. Katz NP, Adams EH, Chilcoat H, et al. Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain. 2007;23(8):648–60.

    Article  PubMed  Google Scholar 

  9. Federation of State Medical Boards of the United States, Inc. Model policy for the use of controlled substances for the treatment of pain. 2004. Available at: http://www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf. Accessed 7 Jan 2010.

  10. Webster LR, Dove B. Avoiding opioid abuse while managing pain: a guide for practitioners. 1st ed. North Branch: Sunrise River Press; 2007. p. 145.

    Google Scholar 

  11. National Institutes of Health, U.S. Department of Health and Human Services. Drugs, brains, and behavior: the science of addiction. NIH Pub No. 07–5605. Printed Apr 2007.

    Google Scholar 

  12. National Institutes of Health, U.S. Department of Health and Human Services. Research report series. Comorbidity: addiction and other mental illnesses. NIH Pub No. 08–5771. Printed Dec 2008.

    Google Scholar 

  13. Zhang Y, Picetti R, Butelman ER, Schlussman SD, Ho A, Kreek MJ. Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice. Neuropsychopharmacology. 2009;34(4):912–22.

    Article  PubMed  CAS  Google Scholar 

  14. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6(2):107–12.

    Article  PubMed  Google Scholar 

  15. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18(4 Suppl):S28–38.

    Article  PubMed  Google Scholar 

  16. Dunbar SA, Katz NP. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11(3):163–71.

    Article  PubMed  CAS  Google Scholar 

  17. Friedman R, Li V, Mehrotra D. Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med. 2003;4(2):182–5.

    Article  PubMed  Google Scholar 

  18. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–230.

    Article  PubMed  CAS  Google Scholar 

  19. Butler SF, Budman SH, Fernandez K, Jamison RN. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112(1–2):65–75.

    Article  PubMed  CAS  Google Scholar 

  20. Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: ­predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7(9):671–81.

    Article  PubMed  Google Scholar 

  21. Coambs RB, Jarry JL. The SISAP; a new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain in general medical practice. Pain Res Manag. 1996;1(3):155–62.

    Google Scholar 

  22. Adams LL, Gatchel RJ, Robinson RC, et al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440–59.

    Article  PubMed  Google Scholar 

  23. Moore TM, Jones T, Browder JH, Daffron S, Passik SD. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med. 2009;10(8):1426–33.

    Article  PubMed  Google Scholar 

  24. Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552–61.

    Article  PubMed  CAS  Google Scholar 

  25. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130(1–2):144–56.

    Article  PubMed  Google Scholar 

  26. Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23(4):307–15.

    Article  PubMed  Google Scholar 

  27. Kaskutas LA. Alcoholics anonymous effectiveness: faith meets science. J Addict Dis. 2009;28(2):145–57.

    Article  PubMed  Google Scholar 

  28. Donovan DM, Floyd AS. Facilitating involvement in twelve-step programs. Recent Dev Alcohol. 2008;18:303–20.

    Article  PubMed  Google Scholar 

  29. Katz N. Patient level opioid risk management: a supplement to the PainEDU.org manual. Newton: Inflexxion, Inc; 2007.

    Google Scholar 

  30. Webster LR. Pharmacogenetics in pain management: the clinical need. Clin Lab Med. 2008;28(4):569–79.

    Article  PubMed  Google Scholar 

  31. Induru RR, Davis MP. Buprenorphine for neuropathic pain: ­targeting hyperalgesia. Am J Hosp Palliat Care. 2009;26(6):470–3.

    Article  PubMed  Google Scholar 

  32. Vadivelu N, Hines RL. Buprenorphine: a unique opioid with broad clinical applications. J Opioid Manag. 2007;3(1):49–58.

    PubMed  Google Scholar 

  33. Malinoff HL, Barkin RL, Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. 2005;12(5):379–84.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Technical writing and manuscript review are provided by Beth Dove of Medical Communications, Salt Lake City, Utah.

Author information

Authors and Affiliations

  1. Clinical Research, 3838 South 700 East, Suite 200, Salt Lake City, UT, 84106, USA

    Lynn Webster M.D.

  2. Mount Sinai School of Medicine, 153 Gaskill Street, Woonsocket, RI, 02895, USA

    Stuart Gitlow M.D., MPH, M.B.A. (Clinical Professor of Medicine)

  3. Mount Sinai School of Medicine, New York, NY, USA

    Stuart Gitlow M.D., MPH, M.B.A. (Clinical Professor of Medicine)

Authors
  1. Lynn Webster M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stuart Gitlow M.D., MPH, M.B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lynn Webster M.D. .

Editor information

Editors and Affiliations

  1. The Center for Pain Relief, Inc., West Virginia University, 400 Court Street, Suite 100, Charleston, 25301, West Virginia, USA

    Timothy R. Deer

  2. Stanford Pain Management Center, Redwood City, CA, Clinic Chief, Stanford University School of Medicine, Stanford, 94065, California, USA

    Michael S. Leong

  3. Department of Anesthesiology, Rush Medical College, Professor, Rush University Medical Center, Chicago, 60612, Illinois, USA

    Asokumar Buvanendran

  4. Pennsylvania State University, College of Medicine, Department of Anesthesiology, Milton S. Hershey Medical Center, Hershey, 17033-0850, Pennsylvania, USA

    Vitaly Gordin

  5. Center for Interventional Pain and Spine, Newark, DE USA, Medical Director, Bryn Mawr Hospital, Bryn Mawr, 19010, Pennsylvania, USA

    Philip S. Kim

  6. President, National Institute of Pain, Tampa, 33558, Florida, USA

    Sunil J. Panchal

  7. The LITE Center, Clinical Associate Professor, Medical Director, School of Medicine, Miami, 33143, Florida, USA

    Albert L. Ray

Rights and permissions

Reprints and permissions

Copyright information

© 2013 American Academy of Pain Medicine

About this chapter

Cite this chapter

Webster, L., Gitlow, S. (2013). Addictive Disorders and Pain. In: Deer, T., et al. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1560-2_73

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1560-2_73

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1559-6

  • Online ISBN: 978-1-4614-1560-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation